Tag: transdermal

September 28, 2018
May 8, 2018

Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights

Zynerba Pharmaceuticals (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare...
May 2, 2018

NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California

NanoSphere Health Sciences (CSE:NSHS), parent company of cannabis brand Evolve Formulas, has joined forces with Vertical™, the largest fully integrated...
April 30, 2018

NanoSphere’s Evolve Formulas Releases CBD Version of Game-Changing NanoSerum™

NanoSphere Health Sciences (CSE:NSHS), parent company of cannabis brand Evolve Formulas, today announced the latest addition to its cannabis product...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 11, 2018

Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for Cannabinoid Delivery and Updates its Expanding Patent Portfolio

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), a drug delivery platform innovator, announces it has received another new Notice of Allowance from the...
April 10, 2018

Zynerba Pharmaceuticals Initiates Open-Label Phase 2 Trial of ZYN002 in Developmental and Epileptic Encephalopathies

Zynerba Pharmaceuticals (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for...